ESR1 and breast cancer: One of the most aggressive and malignant types of breast cancer is the triple negative (estrogen receptor- (ER-), progesterone receptor- (PR-), human epidermal growth factor receptor 2- (HER2-)) basal-like adenocarcinoma.